Elevance Health Inc.

476.91-21.86-4.38%Vol 894.59K1Y Perf 12.90%
Feb 2nd, 2023 13:03 DELAYED
BID476.09 ASK476.97
Open491.83 Previous Close498.77
Pre-Market497.00 After-Market-
 -1.77 -0.35%  - -
Target Price
568.44 
Analyst Rating
Strong Buy 1.29
Potential %
19.68 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     47.00
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★     39.55
Price Range Ratio 52W %
38.24 
Earnings Rating
Market Cap113.90B 
Earnings Date
25th Jan 2023
Alpha0.01 Standard Deviation0.08
Beta0.96 

Today's Price Range

472.95493.68

52W Range

431.96549.52

5 Year PE Ratio Range

9.3026.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-0.68%
1 Month
-2.77%
3 Months
-7.31%
6 Months
5.64%
1 Year
12.90%
3 Years
93.90%
5 Years
120.15%
10 Years
778.66%

TickerPriceChg.Chg.%
ELV476.91-21.8580-4.38
AAPL150.154.71503.24
GOOG107.225.79005.71
MSFT261.849.09003.60
XOM111.79-2.9548-2.58
WFC47.530.50011.06
JNJ164.08-0.8400-0.51
FB196.640.99000.51
GE83.721.40001.70
JPM139.41-0.1800-0.13
 
ProfitabilityValueIndustryS&P 500US Markets
-
5.80
-
4.90
4.34
RevenueValueIndustryS&P 500US Markets
116.67B
488.50
-
-
DividendsValueIndustryS&P 500US Markets
1.09
5.12
13.94
11.77
Payout ratio-
Earnings HistoryEstimateReportedSurprise %
Q04 20225.205.230.58
Q03 20227.107.536.06
Q02 20227.728.044.15
Q01 20227.818.255.63
Q04 20215.115.140.59
Q03 20216.356.796.93
Q02 20216.347.0310.88
Q01 20216.867.012.19
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report5.21
Estimates Count17
EPS Growth Next 5 Years %-
Volume Overview
Volume894.59K
Shares Outstanding238.83K
Shares Float240.81M
Trades Count23.35K
Dollar Volume430.39M
Avg. Volume1.16M
Avg. Weekly Volume1.14M
Avg. Monthly Volume1.25M
Avg. Quarterly Volume1.09M

Elevance Health Inc. (NYSE: ELV) stock closed at 498.77 per share at the end of the most recent trading day (a -0.24% change compared to the prior day closing price) with a volume of 1.24M shares and market capitalization of 113.90B. Is a component of S&P 500 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 98200 people. Elevance Health Inc. CEO is Gail Koziara Boudreaux.

The one-year performance of Elevance Health Inc. stock is 12.9%, while year-to-date (YTD) performance is -2.77%. ELV stock has a five-year performance of 120.15%. Its 52-week range is between 431.96 and 549.52, which gives ELV stock a 52-week price range ratio of 38.24%

Elevance Health Inc. currently has a PE ratio of 18.60, a price-to-book (PB) ratio of 3.16, a price-to-sale (PS) ratio of 0.96, a price to cashflow ratio of 10.00, a PEG ratio of 2.32, a ROA of 6.18%, a ROC of -% and a ROE of 17.32%. The company’s profit margin is 4.34%, its EBITDA margin is -%, and its revenue ttm is $116.67 Billion , which makes it $488.49 revenue per share.

Of the last four earnings reports from Elevance Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.21 for the next earnings report. Elevance Health Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Elevance Health Inc. is Strong Buy (1.29), with a target price of $568.44, which is +19.68% compared to the current price. The earnings rating for Elevance Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elevance Health Inc. has a dividend yield of 1.09% with a dividend per share of $5.12 and a payout ratio of -%.

Elevance Health Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.46, ATR14 : 12.37, CCI20 : 121.61, Chaikin Money Flow : -0.10, MACD : -1.20, Money Flow Index : 60.70, ROC : 3.27, RSI : 54.30, STOCH (14,3) : 73.44, STOCH RSI : 0.81, UO : 52.18, Williams %R : -26.56), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elevance Health Inc. in the last 12-months were: Charles Morgan Kendrick (Option Excercise at a value of $1 806 785), Charles Morgan Kendrick (Sold 6 328 shares of value $3 091 872 ), Peter Haytaian (Option Excercise at a value of $730 699), Peter Haytaian (Sold 53 109 shares of value $24 467 585 ), Ramiro G. Peru (Sold 990 shares of value $464 191 ), Robert L. Dixon (Sold 420 shares of value $208 799 ), Ronald W. Penczek (Option Excercise at a value of $2 343 598), Ronald W. Penczek (Sold 10 372 shares of value $4 752 922 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
12 (85.71 %)
12 (92.31 %)
12 (92.31 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (14.29 %)
1 (7.69 %)
1 (7.69 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.29
Strong Buy
1.15
Strong Buy
1.15

Elevance Health Inc.

Anthem remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Anthem's reach expands beyond those states through government-sponsored programs such as Medicaid, too.

CEO: Gail Koziara Boudreaux

Telephone: +1 800 331-1476

Address: 220 Virginia Avenue, Indianapolis 46204, IN, US

Number of employees: 98 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

Bearish Bullish

57%43%

TipRanks News for ELV

Mon, 16 Jan 2023 05:10 GMT Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Vaxcyte (PCVX) and Morphic Holding (MORF)

- TipRanks. All rights reserved.

Mon, 25 Jul 2022 16:30 GMT Elevance Health (ELV) Gets a Hold Rating from Morgan Stanley

- TipRanks. All rights reserved.

Fri, 22 Jul 2022 09:41 GMT Elevance Health (ELV) Gets a Buy Rating from Jefferies

- TipRanks. All rights reserved.

Thu, 21 Jul 2022 12:26 GMT Elevance Health (ELV) Receives a Rating Update from a Top Analyst

- TipRanks. All rights reserved.

News

Stocktwits